A little over two months after it was announced, Germany-based life sciences firm Merck KGaA said Tuesday that it has completed its $3.9 billion acquisition of Stamford-based SpringWorks Therapeutics Inc.
Get our email newsletters
Stay up-to-date on the companies, people and issues that impact businesses in Hartford and beyond.